Tag: Johnson-and-johnson

johnson and johnson

Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).

Johnson & Johnson — 5 Award-Winning Innovations From Our 2019 Data Science Showcase

Originally published on careers.jnj.com. The 2019 Data Science Showcase at Johnson & Johnson brought together data scientists and business leaders from around the world to collaborate, share cutting-edge breakthroughs and envision the future of healthcare. While there were so many standouts during the three-day event, winners were ultimately selected—based on audience voting—in…

Johnson & Johnson Announces Winners of Champions of Science® Storytelling Challenge – Latin America and the Caribbean Edition

Originally published on jnj.com. Johnson & Johnson today announced five winners of the Champions of Science Storytelling Challenge – Latin America and the Caribbean edition. The Challenge highlights the achievements and personal journeys of scientists and innovators working in the region. “Telling the stories of scientists—what motivates them, how they are approaching…